A dose-dependent response is seen with an increasing number of cardiometabolic diseases and cognitive decline.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Greenspace exposure could improve cognitive function
By
Lois A. Bowers
May 02, 2022
A new study adds to increasing evidence that exposure to greenspace can help improve cognitive function.
ASA: Myocardial infarction may hasten cognitive decline in adults
Feb 03, 2022
Participants with incident MI had significantly faster declines in global cognition, memory and executive function than those without MI
Midlife cardiac structure and its change linked to cognition
Feb 02, 2022
A 25-year increase in left ventricular mass was linked to lower cognition on most tests; an increase in LAV was linked to lower global cognition.
15-minute test could identify subtle signs of dementia quicker than ever: study
By
Kimberly Bonvissuto
Dec 07, 2021
A 15-minute self-administered test developed by researchers at the Ohio State University Wexner Medical Center identified the early, subtle signs of dementia sooner than standard testing, allowing earlier...
Caregivers more likely to have subjective cognitive decline
Nov 19, 2021
“Healthcare professionals can support their patients and their patients’ caregivers by recognizing SCD and its associated challenges in providing care and providing compensatory strategies...
Patients report memory problems after mild COVID-19
Aug 02, 2021
Patients who self-report memory problems eight months after COVID-19 often perceive a worsening of health compared with one year prior.